Does supportive pamidronate treatment prevent or delay the first manifestation of bone metastases in breast cancer patients?
- 1 March 1996
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (3) , 450-454
- https://doi.org/10.1016/0959-8049(95)00564-1
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Prophylactic treatment of skeletal metastases, tumor-induced osteolysis, and hypercalcemia in rats with the bisphosphonate Cl2MBPCancer, 1993
- Palliative pamidronate treatment in patients with bone metastases from breast cancer.Journal of Clinical Oncology, 1993
- Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer.Journal of Clinical Oncology, 1993
- The effect of supportive pamidronate treatment on aspects of quality of life of patients with advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1991
- Steroid hormone receptor activity of primary human breast cancer and pattern of first metastasisBreast Cancer Research and Treatment, 1991
- Locally advanced breast cancer: The contribution of cytotoxic and endocrine treatment to radiotherapyEuropean Journal of Cancer and Clinical Oncology, 1989
- The Pattern of Metastases in Human Breast Cancer Influence of systemic adjuvant therapy and impact on survivalActa Oncologica, 1988
- REDUCED MORBIDITY FROM SKELETAL METASTASES IN BREAST CANCER PATIENTS DURING LONG-TERM BISPHOSPHONATE (APD) TREATMENTThe Lancet, 1987
- Osteolytic bone metastases in breast carcinoma pathogenesis, morbidity and biphosphonate treatmentEuropean Journal of Cancer and Clinical Oncology, 1986
- LONG-TERM CONTROLLED TRIAL WITH DIPHOSPHONATE IN PATIENTS WITH OSTEOLYTIC BONE METASTASESThe Lancet, 1983